Lista de obras - Xiaoming Xie - Dominio Público Uruguay

A nation-wide multicenter retrospective study of the epidemiological, pathological and clinical characteristics of breast cancer in situ in Chinese women in 1999 - 2008.

artículo científico publicado en 2013

A novel hTERT promoter-driven E1A therapeutic for ovarian cancer.

artículo científico publicado en 2009

AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer.

artículo científico publicado en 2017

Absence of evidence for epidermal growth factor receptor and human homolog of the Kirsten rat sarcoma-2 virus oncogene mutations in breast cancer

artículo científico publicado en 2012

BikDD eliminates breast cancer initiating cells and synergizes with lapatinib for breast cancer treatment

artículo científico publicado en 2011

Clinicopathological and Prognostic Significance of Cancer Antigen 15-3 and Carcinoembryonic Antigen in Breast Cancer: A Meta-Analysis including 12,993 Patients.

artículo científico publicado en 2018

Cytokeratin19-2g2, a novel fragment of cytokeratin19 in serum, indicating a more invasive behavior and worse prognosis in breast cancer patients

artículo científico publicado en 2013

Development of PEA-15 using a potent non-viral vector for therapeutic application in breast cancer

artículo científico publicado en 2014

Diallyl disulfide suppresses proliferation and induces apoptosis in human gastric cancer through Wnt-1 signaling pathway by up-regulation of miR-200b and miR-22.

artículo científico publicado en 2013

Direct inhibition of ACTN4 by ellagic acid limits breast cancer metastasis via regulation of β-catenin stabilization in cancer stem cells

artículo científico publicado en 2017

ERβ1 inversely correlates with PTEN/PI3K/AKT pathway and predicts a favorable prognosis in triple-negative breast cancer.

artículo científico publicado en 2015

EZH2 promotes expansion of breast tumor initiating cells through activation of RAF1-β-catenin signaling

artículo científico publicado en 2011

Efficacy of PI3K/AKT/mTOR pathway inhibitors for the treatment of advanced solid cancers: A literature-based meta-analysis of 46 randomised control trials.

artículo científico publicado en 2018

Endostatin-cytosine deaminase fusion protein suppresses tumor growth by targeting neovascular endothelial cells

artículo científico publicado en 2006

Epidermal growth factor receptor in breast carcinoma: association between gene copy number and mutations.

artículo científico publicado en 2011

High serum HER2 extracellular domain levels: correlation with a worse disease-free survival and overall survival in primary operable breast cancer patients

artículo científico publicado en 2011

LGR5 Promotes Breast Cancer Progression and Maintains Stem-Like Cells Through Activation of Wnt/β-Catenin Signaling

artículo científico publicado en 2015

Microrna-124 targets flotillin-1 to regulate proliferation and migration in breast cancer

artículo científico publicado en 2013

Myeloid cell leukemia-1 inversely correlates with glycogen synthase kinase-3beta activity and associates with poor prognosis in human breast cancer.

artículo científico publicado en 2007

N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancer

artículo científico publicado en 2022

Nanoparticle Delivery of miR-34a Eradicates Long-term-cultured Breast Cancer Stem Cells via Targeting C22ORF28 Directly

artículo científico publicado en 2017

PDL1 And LDHA act as ceRNAs in triple negative breast cancer by regulating miR-34a

artículo científico publicado en 2017

POMC maintains tumor-initiating properties of tumor tissue-derived long-term-cultured breast cancer stem cells

artículo científico publicado en 2017

Preoperative prediction nomogram based on primary tumor miRNAs signature and clinical-related features for axillary lymph node metastasis in early-stage invasive breast cancer

artículo científico publicado en 2017

Risk factors and survival outcomes in patients with breast cancer and lung metastasis: a population-based study.

artículo científico publicado en 2018

Targeted BikDD expression kills androgen-dependent and castration-resistant prostate cancer cells.

artículo científico publicado en 2014

Targeted expression of BikDD eliminates breast cancer with virtually no toxicity in noninvasive imaging models.

artículo científico publicado en 2012

Targeted expression of BikDD eradicates pancreatic tumors in noninvasive imaging models

scientific article published on 01 July 2007

Targeted expression of miR-34a using the T-VISA system suppresses breast cancer cell growth and invasion

artículo científico publicado en 2012

The value of neutrophil-to-lymphocyte ratio for response and prognostic effect of neoadjuvant chemotherapy in solid tumors: A systematic review and meta-analysis.

artículo científico publicado en 2018

miR-185 suppresses tumor proliferation by directly targeting E2F6 and DNMT1 and indirectly upregulating BRCA1 in triple-negative breast cancer

artículo científico publicado en 2014

miR-200b and miR-200c as prognostic factors and mediators of gastric cancer cell progression.

artículo científico publicado en 2013

miR-22 as a prognostic factor targets glucose transporter protein type 1 in breast cancer

scientific article published on 07 October 2014

miR-26a suppresses tumour proliferation and metastasis by targeting metadherin in triple negative breast cancer.

artículo científico publicado en 2014

miR-629-3p may serve as a novel biomarker and potential therapeutic target for lung metastases of triple-negative breast cancer

artículo científico publicado en 2017

Lista de obras de Xiaoming Xie

A nation-wide multicenter retrospective study of the epidemiological, pathological and clinical characteristics of breast cancer in situ in Chinese women in 1999 - 2008.

A novel hTERT promoter-driven E1A therapeutic for ovarian cancer.

AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer.

Absence of evidence for epidermal growth factor receptor and human homolog of the Kirsten rat sarcoma-2 virus oncogene mutations in breast cancer

BikDD eliminates breast cancer initiating cells and synergizes with lapatinib for breast cancer treatment

Clinicopathological and Prognostic Significance of Cancer Antigen 15-3 and Carcinoembryonic Antigen in Breast Cancer: A Meta-Analysis including 12,993 Patients.

Cytokeratin19-2g2, a novel fragment of cytokeratin19 in serum, indicating a more invasive behavior and worse prognosis in breast cancer patients

Development of PEA-15 using a potent non-viral vector for therapeutic application in breast cancer

Diallyl disulfide suppresses proliferation and induces apoptosis in human gastric cancer through Wnt-1 signaling pathway by up-regulation of miR-200b and miR-22.

Direct inhibition of ACTN4 by ellagic acid limits breast cancer metastasis via regulation of β-catenin stabilization in cancer stem cells

ERβ1 inversely correlates with PTEN/PI3K/AKT pathway and predicts a favorable prognosis in triple-negative breast cancer.

EZH2 promotes expansion of breast tumor initiating cells through activation of RAF1-β-catenin signaling

Efficacy of PI3K/AKT/mTOR pathway inhibitors for the treatment of advanced solid cancers: A literature-based meta-analysis of 46 randomised control trials.

Endostatin-cytosine deaminase fusion protein suppresses tumor growth by targeting neovascular endothelial cells

Epidermal growth factor receptor in breast carcinoma: association between gene copy number and mutations.

High serum HER2 extracellular domain levels: correlation with a worse disease-free survival and overall survival in primary operable breast cancer patients

LGR5 Promotes Breast Cancer Progression and Maintains Stem-Like Cells Through Activation of Wnt/β-Catenin Signaling

Microrna-124 targets flotillin-1 to regulate proliferation and migration in breast cancer

Myeloid cell leukemia-1 inversely correlates with glycogen synthase kinase-3beta activity and associates with poor prognosis in human breast cancer.

N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancer

Nanoparticle Delivery of miR-34a Eradicates Long-term-cultured Breast Cancer Stem Cells via Targeting C22ORF28 Directly

PDL1 And LDHA act as ceRNAs in triple negative breast cancer by regulating miR-34a

POMC maintains tumor-initiating properties of tumor tissue-derived long-term-cultured breast cancer stem cells

Preoperative prediction nomogram based on primary tumor miRNAs signature and clinical-related features for axillary lymph node metastasis in early-stage invasive breast cancer

Risk factors and survival outcomes in patients with breast cancer and lung metastasis: a population-based study.

Targeted BikDD expression kills androgen-dependent and castration-resistant prostate cancer cells.

Targeted expression of BikDD eliminates breast cancer with virtually no toxicity in noninvasive imaging models.

Targeted expression of BikDD eradicates pancreatic tumors in noninvasive imaging models

Targeted expression of miR-34a using the T-VISA system suppresses breast cancer cell growth and invasion

The value of neutrophil-to-lymphocyte ratio for response and prognostic effect of neoadjuvant chemotherapy in solid tumors: A systematic review and meta-analysis.

miR-185 suppresses tumor proliferation by directly targeting E2F6 and DNMT1 and indirectly upregulating BRCA1 in triple-negative breast cancer

miR-200b and miR-200c as prognostic factors and mediators of gastric cancer cell progression.

miR-22 as a prognostic factor targets glucose transporter protein type 1 in breast cancer

miR-26a suppresses tumour proliferation and metastasis by targeting metadherin in triple negative breast cancer.

miR-629-3p may serve as a novel biomarker and potential therapeutic target for lung metastases of triple-negative breast cancer